Access to anti-retroviral drugs, female in Namibia
Namibia: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Namibia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Namibia is 98.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 1.0% on the previous year and up 71.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Namibia peaked at 98.0% in 2024 and was at its lowest, 0.0%, in 2000.
Namibia ranks 1st of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Namibia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 3.0% | — |
| 2005 | 8.0% | +166.7% |
| 2006 | 15.0% | +87.5% |
| 2007 | 26.0% | +73.3% |
| 2008 | 32.0% | +23.1% |
| 2009 | 35.0% | +9.4% |
| 2010 | 42.0% | +20.0% |
| 2011 | 50.0% | +19.0% |
| 2012 | 55.0% | +10.0% |
| 2013 | 58.0% | +5.5% |
| 2014 | 57.0% | -1.7% |
| 2015 | 63.0% | +10.5% |
| 2016 | 67.0% | +6.3% |
| 2017 | 75.0% | +11.9% |
| 2018 | 78.0% | +4.0% |
| 2019 | 86.0% | +10.3% |
| 2020 | 88.0% | +2.3% |
| 2021 | 91.0% | +3.4% |
| 2022 | 93.0% | +2.2% |
| 2023 | 97.0% | +4.3% |
| 2024 | 98.0% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.9% | 0.0% | 35.0% | 10 |
| 2010s | 63.1% | 42.0% | 86.0% | 10 |
| 2020s | 93.4% | 88.0% | 98.0% | 5 |
Countries ranked near Namibia
More gender data for Namibia
- Child population (UN estimates and projections) 1,172 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.3037 % change on previous year (2030)
- Age population, age 00, female, interpolated 38,320 (2025)
- Age population, age 00, male, interpolated 38,517 (2025)
- Age population, age 01, female, interpolated 37,694 (2025)
- Age population, age 01, male, interpolated 37,867 (2025)
- Age population, age 02, female, interpolated 38,396 (2025)
- Age population, age 02, male, interpolated 38,539 (2025)
- Age population, age 03, female, interpolated 41,370 (2025)
- Age population, age 03, male, interpolated 41,570 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Namibia?
- Access to anti-retroviral drugs, female in Namibia was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Namibia?
- The highest recorded value was 98.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Namibia?
- The lowest recorded value was 0.0% in 2000.
- How does Namibia rank for access to anti-retroviral drugs, female?
- Namibia ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Namibia?
- Over the last ten years it is up 71.9%. The long-run trend across the full record is volatile.
- Where does this Namibia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.